03-30-2020, 05:36 AM
From: https://finance.yahoo.com/news/fda-appro...08197.html
FDA approves emergency use of malaria pill for COVID-19 treatment
Which begins..
The Food and Drug Administration on Sunday approved the anecdotally promising malaria drug for emergency use to treat hospitalized patients for COVID-19.
The U.S. Department of Health and Human Services (HHS) said in a statement it has accepted 30 million doses of hydroxychloroquine sulfate donated by Sandoz, the Novartis (NVS) generics and biosimilars division, and one million doses of chloroquine phosphate donated by Bayer Pharmaceuticals (BAYRY).
The drug is currently being tested in New York hospitals.
The drug’s effects on patients has result in a shortage for patients who use it for arthritis and lupus, and there have been reports of hoarding among medical professionals. Several states recently took steps to limit the number of prescriptions filled, by forcing increased accountability of who is prescribing the drug and why...
The rest of the article is at the link above..
FDA approves emergency use of malaria pill for COVID-19 treatment
Which begins..
The Food and Drug Administration on Sunday approved the anecdotally promising malaria drug for emergency use to treat hospitalized patients for COVID-19.
The U.S. Department of Health and Human Services (HHS) said in a statement it has accepted 30 million doses of hydroxychloroquine sulfate donated by Sandoz, the Novartis (NVS) generics and biosimilars division, and one million doses of chloroquine phosphate donated by Bayer Pharmaceuticals (BAYRY).
The drug is currently being tested in New York hospitals.
The drug’s effects on patients has result in a shortage for patients who use it for arthritis and lupus, and there have been reports of hoarding among medical professionals. Several states recently took steps to limit the number of prescriptions filled, by forcing increased accountability of who is prescribing the drug and why...
The rest of the article is at the link above..